Drug Discovery World
NOVEMBER 9, 2023
The luncheon presentation will be given by Hans Gerstmans, Postdoctoral Researcher, Laboratory for Biomolecular Discovery & Engineering, KU Leuven, VIB, alongside Wai Long Tam, Head of Technology Watch at VIB, Technology Watch, VIB.
Drug Discovery World
NOVEMBER 8, 2023
Adams, on a first-in-human study of ELU001, a targeted c’dot drug conjugate, in subjects with folate receptor α (frα) overexpressing solid tumours, and Groothuis on the non-clinical pharmacology of the MET-targeting ADC BYON3521. He will cover the evaluation of safety and efficacy of antibody therapies in PBMC humanised mice.
Expert insights. Personalized for you.
130 
Let's personalize your content